Tuesday, 30 August 2011

Medical Imaging Markets: Image-Guided Surgery

Published: August 2011
No. of Pages:130
Price: $ 3500

Imaging technology used to diagnose illness and injury is increasingly being used to assist surgeons complete procedures. Interventional radiology or image-guided surgery involves the use of a real-time correlation of the operative field to preoperative imaging data that reflect the precise location of a surgical instrument to the surrounding anatomical structures. Preoperative scans from different imaging modalities provide additional diagnostic information. These scans can help a surgeon assess the adequacy of a repair.

As the number of minimally invasive surgical procedures has increased, though, other imaging modalities have been applied to address the limitations of x-rays and fluoroscopy. Computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and molecular imaging have provided the information required to plan and perform complex interventions inside the body without the need for direct open visual inspection by a surgeon.

Kalorama Information's Medical Imaging Markets: Image-Guided Surgery provides insight into the use of imaging to assist surgical performance, with procedure and market data for the US, Europe, Asia and ROW for the following modalities:
• X-Ray Fluoroscopy
• CT
• Ultrasound
The report also provides revenue and procedure numbers based on procedures completed.

The following companies active in this field are profiled:
• B K Medical
• Brainlab AG
• Compass International Innovations
• Curexo Technology Corp.
• Elekta AB
• GE Healthcare
• Image Guided Therapy
• Imris
• Integra Lifesciences Holdings
• Medtronic
• NDS Surgical Imaging
• Philips Healthcare
• Siemens Healthcare
• SiteSelect Inc.
• Smith & Nephew plc
• St. Jude Medical Inc.
• Stryker Corp.
• SurgiVision Inc.
• Toshiba America Medical Systems Inc.
• TrueVision Systems
• Ultrasonix Medical Corp.
• Xograph Healthcare Ltd.
• Varian Medical Systems Inc.
• Vital Images Inc.
• Zimmer

The report also examines trends in the industry, including:
• Partnering for Image-Guided Surgery
• Improved Vascular Guidance
• Image-Guided Biopsies on the Rise
• Radiologists’ Role Increases
• Reducing Radiation Exposure
• Reducing Shoulder Pain
• Improving Spinal Surgery Outcomes
• Cone-Beam Computed Tomography
• Greater Use of Needle Biopsies
• MIS Lateral Approach Platform
• Image and Robotic Guidance
• MR-Guided Ultrasound

Tuesday, 16 August 2011

Out of Pocket Healthcare Spending 2011

Published: April 2011
No. of Pages: 85
Price: $ 1995

The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates. According to the U.S. Department of Labor, the average household's spending on health care after inflation has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket costs rising by more than 2% each year as a result of increased spending on prescription drugs.

While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Unique financial services have been created to facilitate non-insurance-paid health care services, and more are expected to be created in the near term.

This report, Out of Pocket Healthcare Spending 2011 focuses on those costs of health care which are not paid for by government or private insurance. Once a small percentage of costs of the health care system, the percentage borne by the consumer is increasing steadily. Included in the report is:
• Estimates of the Current 'Out of Pocket' Healthcare Spending Market and Forecasts to 2015.
• Breakdown of Spending by Type (Elective, Hospital, Emergency Room, Dental, Vision Outpatient, Prescription Drugs, Office Based Visit, Other)
• Health Care Reform and Its Impact on Out of Pocket Spending
• Statistics For the Types of Consumers Most Likely to Pay Out of Pocket
• Drivers of the Out of Pocket Trend and Potential Limiters
• Overview of the U.S. Healthcare System, Insured and Uninsured Population.
• The Types of Services and Products Purchased with Out of Pocket dollars
• Overview of the growing Healthcare Finance market and a look at key competitors.
The economic recession of December 2007 to October 2009 represented a major downturn that led to broad-based cost-cutting, rising unemployment and reduced disposable income. The impact of the pullback - which some experts compared to the Great Depression of 1929 to 1934 - cannot be overstated. Kalorama Information looks at what change has resulted in out of pocket expenditure for healthcare as a result of the recession and weak recovery.

As part of Kalorama Information's trusted process, secondary research from government, medical and industry sources was utilized along with interviews with industry experts in the healthcare finance industry.

In Weak Recovery, Consumers Bearing More of Healthcare Costs

Healthcare costs paid out-of-pocket by consumers have increased steadily in recent years, but according to Kalorama Information, the recession and weak recovery are additional drivers for the trend. In fact, the independent healthcare market research firm has found in its new report, Out of Pocket Healthcare Spending 2011, that out-of-pocket healthcare spending was $303 billion in 2010 and the rate of growth will accelerate at 8% annually in the coming years.

According to the U.S. Department of Labor, the average household's inflation-adjusted spending on healthcare has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket healthcare costs rising by more than 2% each year as a result of increased spending on prescription drugs.

"The recent recession brought with it a high unemployment rate, exacerbated by increased outsourcing of jobs to lower cost countries, broad-based cost-cutting and reduced disposable income," said Bruce Carlson, publisher of Kalorama Information. "Meanwhile, affordable healthcare has become less available but more necessary."

The costs of healthcare products and services continue to rise briskly; in some cases, they have become astronomical. For example, in 2010, average annual healthcare premiums for a family of four ($13,770) approached annual earnings at the federal minimum wage ($14,500). As a result, Kalorama notes that managed care organizations are increasingly shifting the burden of healthcare costs to consumers by way of increased co-pays and premiums.

About 70% of consumers' out-of-pocket healthcare spending goes to premiums. And this is increasing as HMOs and employers engage in cost shifting. Co-pays make up a little over 3% of spending, which Kalorama also expects to increase due to cost shifting. Another 27% of out-of-pocket spending goes to direct payments.

The Health Care Reform of 2010 has significantly changed the landscape of the U.S. healthcare industry by extending healthcare coverage to approximately 32 million previously uninsured people. Although this could potentially decrease some demand for out-of-pocket spending from the previously uninsured, it may in fact, raise awareness of the value of basic care and bring more persons into the medical system, thus potentially increasing spending as newly insured consumers take a renewed interest in their health and wellness.

Tuesday, 9 August 2011

Minimally Invasive Surgical Devices, World Market

Published: May 2011
No. of Pages:150
Price: $ 3500

Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the Minimally Invasive Surgical devices market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers. Additionally key company profiles are included.

Browse All: Healthcare Market Research

The report provides total market sizes in six general surgery areas reflecting revenues earned by all manufacturers in all MIS methods in those areas. Revenues for each therapeutic area. were gathered through both primary and secondary research methods. General surgery areas include:
• Orthopedic MIS Device Market (included in total market size number in this report are arthoscopes, autoclavable laoparoscope, holmium lasers, other devices)
• Neurosurgery MIS Device Market (included in total market size number in this report are neuroendoscopes, bronchoscope, esophoscope, others)
• ENT/Respiratory MIS Device Market (included in total market size number in this report are laryngoscopes, ventriculoscopes, contact lasers, others)
• Cardiovascular MIS Device Market (included in total market size figure are laparoscopes, ablation systems, endoscopes, others)
• Gastrointestinal System MIS Device Market (included in total market size figure are endoscopes, sigmoidoscopes, videoscopes, others)
• Urological and Gynecological MIS Device Market (included in total market size figure are hysteroscopes, cystoscopes, others)
The purpose of this report is to provide understanding of the total current market for all MIS methods for each therapeutic area. In the scope of this report they are considered as competitive methods and are not broken down to specific device segments (for instance 'Gastroinestinal System Devices' will contain a number for all competiting MIS methods in GI, but will not have a specific sigmoidoscope or GI endoscope number.)

Five year forecasts are also provided. As this is a global survey, Revenues are provided for the following regions:
• US
• Europe
• Rest of World

Procedure volumes are available for the following surgeries for which minimally invasive equipment is utilized:
• Hip Replacement, Pinning, etc.
• Knee Repair/Fixation, Procedures
• Spinal Fusion/Spinal Hardware Removal
• Shoulder Repair/Fixation
• Lumbar Laminectomy/ Thoracic-lumbar
• Laminectomy/Diskectomy and Lumbar Decompression and Fusion
• Craniotomy (all types)
• Ventricular-Peritoneal Shunt Insertion/ Removal/Revision
• Detether Cord (adult and pediatric)
• Ethmoidectomy
• Tonsillectomy
• Thyroidectomy
• Coronary Revascularization
• Aortic Valve Replacement or Repair
• Cardiac Catheterization
• Insertion of Coronary Artery Stent(s)
• Appendectomy
• Endoscopy with or without biopsy
• Cholecystectomy
• Inguinal Herniorrhaphy
• Hysterectomy (all types)
• Prostatectomy

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 45 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives:
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Compound annual growth rates (CAGRs) are provided for each region and/or segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for was largely based on demographic trends, new developments, and global expansion.